Document is current
Any future updates will be listed below
-
Authors
Nguyen Ngoc Pouplin, Julie
Kaendiao, Thoopmanee
Rahimi, Bilal Ahmad
Soni, Mayur
Basopia, Hensi
Shah, Darshana
Patil, Jitendra
Dholakia, Vyom
Suthar, Yash
Tarning, Joel
Mukaka, Mavuto
Taylor, Walter R.
-
Clinical Trials BETA
Clinical trials referenced in this document:
isrctn54640699 at ISRCTN.orgDocuments that mention this clinical trial
Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
https://doi.org/10.1186/s12936-024-04947-6
-
Funding
Funding for this research was provided by:
MRC (MR/V027522/1)
- License Information
-
More Information
Article History
Received: 14 December 2023
Accepted: 12 April 2024
First Online: 5 June 2024
Declarations
:
: The study was approved by the: (i) Ibiome Independent Ethics Committee (IBIOME-IEC) on 28th November 22, and (ii) the Oxford University Tropical Ethics Committee (OxTREC Reference: 40-21). The study protocol was also reviewed by the Prequalification team at the WHO Geneva, in accordance with their standard practice for studies intended for WHO prequalification.
: Not applicable.
: All authors declare that they have no competing interests.
